Technical Analysis for BIO - Bio-Rad Laboratories, Inc.

Grade Last Price % Change Price Change
grade A 217.78 1.33% 2.86
BIO closed up 1.33 percent on Thursday, April 27, 2017, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: May 4

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BIO trend table...

Date Alert Name Type % Chg
Apr 27 New 52 Week High Bullish 0.00%
Apr 27 Upper Bollinger Band Walk Other 0.00%
Apr 26 New 52 Week High Bullish 1.33%
Apr 26 New Uptrend Bullish 1.33%
Apr 26 Upper Bollinger Band Walk Other 1.33%
Apr 26 Slingshot Bullish Bullish Swing Setup 1.33%
Apr 26 180 Bullish Setup Bullish Swing Setup 1.33%
Apr 25 New 52 Week High Bullish 2.18%
Apr 25 Stochastic Sell Signal Bearish 2.18%
Apr 25 Upper Bollinger Band Walk Other 2.18%

Older signals for BIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 219.34
52 Week Low 135.94
Average Volume 216,536
200-Day Moving Average 175.5595
50-Day Moving Average 200.3508
20-Day Moving Average 205.835
10-Day Moving Average 210.407
Average True Range 3.1533
ADX 28.9
+DI 40.82
-DI: 10.44
Chandelier Exit (Long, 3 ATRs) 209.8801
Chandelier Exit (Short, 3 ATRs) 204.9599
Upper Bollinger Band 217.3079
Lower Bollinger Band 194.3621
Percent B (%b) 1.02
Bandwidth 0.111477